Back to Search Start Over

Evaluation of confirmatory data following the Article 12 MRL review for paclobutrazol.

Authors :
Bellisai, Giulia
Bernasconi, Giovanni
Brancato, Alba
Cabrera, Luis Carrasco
Castellan, Irene
Del Aguila, Monica
Ferreira, Lucien
Santonja, German Giner
Greco, Luna
Jarrah, Samira
Leuschner, Renata
Magrans, Jose Oriol
Miron, Ileana
Nave, Stefanie
Pedersen, Ragnor
Reich, Hermine
Robinson, Tobin
Ruocco, Silvia
Santos, Miguel
Scarlato, Alessia Pia
Source :
EFSA Journal; Nov2022, Vol. 20 Issue 11, p1-26, 26p
Publication Year :
2022

Abstract

The applicant Proplan Plant Protection Company submitted a request to the competent national authority in Austria (originally the United Kingdom) to evaluate the confirmatory data that were identified for paclobutrazol in the framework of the MRL review under Article 12 of Regulation (EC) No 396/2005 as not available. To address the data gaps, two new metabolism studies performed on apples were submitted. In addition, two studies on the magnitude of residues in apples and pears providing data for triazole derivative metabolites were also submitted. The data gaps were considered satisfactorily addressed. The new information provided did not require a revision of the existing MRLs for pome fruits, apricots and peaches. An update of the risk assessment was performed for paclobutrazol and for the triazole derivative metabolites in light of the new data submitted and did not indicate any consumer intake concerns. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
18314732
Volume :
20
Issue :
11
Database :
Complementary Index
Journal :
EFSA Journal
Publication Type :
Academic Journal
Accession number :
160509407
Full Text :
https://doi.org/10.2903/j.efsa.2022.7651